Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Early events of human T lymphocyte activation are associated with type I protein kinase A activity.
D Laxminarayana, … , A Berrada, G M Kammer
D Laxminarayana, … , A Berrada, G M Kammer
Published November 1, 1993
Citation Information: J Clin Invest. 1993;92(5):2207-2214. https://doi.org/10.1172/JCI116823.
View: Text | PDF
Research Article

Early events of human T lymphocyte activation are associated with type I protein kinase A activity.

  • Text
  • PDF
Abstract

Human T lymphocytes possess both the type I and II isozymes of protein kinase A (PKA). The type I (PKA-I) isozyme is predominantly associated with the plasma membrane, whereas the type II (PKA-II) isozyme is primarily localized to the cytosol. Because the functions of both PKA-I and PKA-II isozymes in the biochemical events of T lymphocyte activation have not been clearly elucidated, we tested the hypothesis that very early events of normal human T lymphocyte activation are mediated by the PKA-I and/or PKA-II isozyme(s). Fresh normal human T cells and a normal human CD4+ T cell line (GK606) activated with anti-CD3-epsilon and recombinant interleukin 1 alpha (rIL-1 alpha) exhibited a peak six- to sevenfold increase of PKA phosphotransferase activity at 5 min that returned to baseline by 60 min. Similarly, both fresh T cells and the T cell line activated by phorbol myristate acetate and ionomycin demonstrated a peak eightfold increase of PKA activity by 15 min that returned toward baseline by 60 min. Chromatographic separation of the PKA isozymes and quantification of phosphotransferase activities after T cell activation by either agonist pair showed preferential activation of the PKA-I isozyme, resulting in a significant reduction in the ratio of PKA-I to PKA-II isozyme activity from 3.1:1-6.2:1 to 1.1:1-3.2:1. PKA-I isozyme activation resulted in the release of free catalytic (C) subunit, an increase in C subunit phosphotransferase activity, and the phosphorylation of T cell plasma membrane-associated proteins, p14, p17, p20, p21, p38, and p48. However, activation of the PKA-I isozyme did not appear to be required for the transcription of IL-2 mRNA, an event necessary for mitosis. These data indicate that ligand-induced T cell activation is associated with rapid activation of the PKA-I, but not PKA-II, isozyme that results in phosphorylation of plasma membrane-associated proteins. The involvement of the PKA-I isozyme during the very early events of T cell activation suggests that this isozyme may be an antigen- or mitogen-stimulated protein kinase.

Authors

D Laxminarayana, A Berrada, G M Kammer

×

Total citations by year

Year: 2017 2010 2007 2006 2004 2002 2001 2000 1999 1998 1997 1996 1995 1994 Total
Citations: 1 1 1 1 3 2 1 5 3 6 5 1 3 1 34
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (34)

Title and authors Publication Year
Lupus
WA Khan
Lupus 2017
Regulation of T cells in airway disease by beta-agonist
MJ Loza, RB Penn
Frontiers in bioscience (Scholar edition) 2010
Induction of 150-kDa adenosine deaminase that acts on RNA (ADAR)-1 gene expression in normal T lymphocytes by anti-CD3-epsilon and anti-CD28
D Laxminarayana, IU Khan, KS O'Rourke, B Giri
Immunology 2007
Beta-agonists modulate T-cell functions via direct actions on type 1 and type 2 cells
MJ Loza, S Foster, SP Peters, RB Penn
Blood 2006
MECHANISMS OF DEFICIENT TYPE I PROTEIN KINASE A ACTIVITY IN LUPUS T LYMPHOCYTES
GM Kammer, D Laxminarayana, IU Khan
International Reviews of Immunology 2004
T cell receptor induced intracellular redistribution of type I protein kinase A
W Zhou, L Vergara, R König
Immunology 2004
Down-Regulation of IL-2 Production in T Lymphocytes by Phosphorylated Protein Kinase A-RIIβ
MR Elliott, RA Shanks, IU Khan, JW Brooks, PJ Burkett, BJ Nelson, V Kyttaris, YT Juang, GC Tsokos, GM Kammer
Journal of immunology (Baltimore, Md. : 1950) 2004
HA1004, an inhibitor of serine/threonine protein kinases, restores the sensitivity of thymic lymphomas to Ca2+-mediated apoptosis through a protein kinase A-independent mechanism
J Matuszyk, M Cebrat, W Kalas, L Strzadala
International Immunopharmacology 2002
Commitment of Activated T Cells to Secondary Responsiveness Is Enhanced by Signals Mediated by cAMP-Dependent Protein Kinase A-I
M Vig, A George, R Sen, J Durdik, S Rath, V Bal
Molecular pharmacology 2002
Protein Kinase A RIβ Subunit Deficiency in Lupus T Lymphocytes: Bypassing a Block in RIβ Translation Reconstitutes Protein Kinase A Activity and Augments IL-2 Production
IU Khan, D Laxminarayana, GM Kammer
Journal of immunology (Baltimore, Md. : 1950) 2001
Generation of stable cell lines by spontaneous immortalization of primary cultures of porcine granulosa cells
C Gillio-Meina, CL Swan, NK Crellin, DM Stocco, PJ Chedrese
Molecular Reproduction and Development 2000
Molecular aberrations in human systemic lupus erythematosus
GC Tsokos, GM Kammer
Molecular Medicine Today 2000
mRNA mutations of type I protein kinase A regulatory subunit α in T lymphocytes of a subject with systemic lupus erythematosus
D Laxminarayana, GM Kammer
International Immunology 2000
Association of Deficient Type II Protein Kinase A Activity with Aberrant Nuclear Translocation of the RIIβ Subunit in Systemic Lupus Erythematosus T Lymphocytes
N Mishra, IU Khan, GC Tsokos, GM Kammer
Journal of immunology (Baltimore, Md. : 1950) 2000
Targeting of epidermal growth factor receptor and protein kinase A: Molecular basis and therapeutic applications
G Tortora, F Ciardiello
Annals of Oncology 2000
Beta-adrenergic receptor agonists and cyclic nucleotide phosphodiesterase inhibitors: shifting the focus from inotropy to cyclic adenosine monophosphate
MA Movsesian
Journal of the American College of Cardiology 1999
Antisense Therapeutics in Oncology: Points to Consider in Their Clinical Evaluation
S Mani, Y Gu, S Wadler, H Fingert
Antisense and Nucleic Acid Drug Development 1999
High prevalence of T cell type I protein kinase a deficiency in systemic lupus erythematosus
GM Kammer
Arthritis & Rheumatism 1999
Effect of PGE2 on the cell surface molecule expression in PMA treated thymocytes
R Daculsi, D Vaillier, JC Carron, N Gualde
Immunology Letters 1998
Protein kinase A type I antagonist restores immune responses of T cells from HIV-infected patients
EM Aandahl, P Aukrust, BS Skålhegg, F Müller, SS Frøland, V Hansson, K Taskén
The FASEB Journal 1998
Regulation of adenylyl cyclase activity in human peripheral blood mononuclear cells: effects of protein kinase inhibitors and of a calcium ionophore
HA Buc, A Moncion, JL Pérignon
International Journal of Immunopharmacology 1998
Co-regulation of antigen-specific t lymphocyte responses by type i and type ii cyclic amp-dependent protein kinases (cak)
CM Braun, SK Huang, A Kagey-Sobotka, LM Lichtenstein, DM Essayan
Biochemical Pharmacology 1998
Protein kinase A-catalyzed phosphorylation of heat shock protein 60 chaperone regulates its attachment to histone 2B in the T lymphocyte plasma membrane
IU Khan, R Wallin, RS Gupta, GM Kammer
Proceedings of the National Academy of Sciences 1998
Protein kinase A-catalyzed phosphorylation of heat shock protein 60 chaperone regulates its attachment to histone 2B in the T lymphocyte plasma membrane.
Khan IU, Wallin R, Gupta RS, Kammer GM
Proceedings of the National Academy of Sciences 1998
Transient CRE- and κB site-binding is cross-regulated by cAMP-dependent protein kinase and a protein phosphatase in mouse splenocytes
WS Koh, YJ Jeon, AC Herring, NE Kaminski
Life Sciences 1997
Inhibition of protein kinase A and cyclic AMP response element (CRE)-specific transcription factor binding by Δ9-tetrahydrocannabinol (Δ9-THC)
WS Koh, RB Crawford, NE Kaminski
Biochemical Pharmacology 1997
Serotonin Modulates Immune Function in T Cells from HIV-Seropositive Subjects
J Eugen-Olsen, P Afzelius, L Andresen, J Iversen, G Kronborg, P Aabech, JO Nielsen, B Hofmann
Clinical Immunology and Immunopathology 1997
Analysis of the in vitro effect of exogenous nitric oxide on human lymphocytes
A S Shoker, H Yang, M A Murabit, H Jamil, A al-Ghoul, K Okasha
Molecular and Cellular Biochemistry 1997
Inhibition of human lymphocyte function by organic solvents
A S Shoker, M A Murabit, F F Georges, L F Qualtiere, H G Deneer, K Prasad
Molecular and Cellular Biochemistry 1997
The T cell enigma in lupus
AK Dayal, GM Kammer
Arthritis & Rheumatism 1996
Regulation of interferon-γ mRNA in a cytolytic T cell clone: Ca2+-induced transcription followed by mRNA stabilization through activation of protein kinase C or increase in cAMP
P Kaldy, AM Schmitt-Verhulst
European Journal of Immunology 1995
Immunosuppressive retroviral peptides: cAMP and cytokine patterns
S Haraguchi, RA Good, NK Day
Immunology Today 1995
Ion Channels in Inexcitable Cells
H Sontheimer
The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry 1995
Deficient type I protein kinase A isozyme activity in systemic lupus erythematosus T lymphocytes
GM Kammer, IU Khan, CJ Malemud
Journal of Clinical Investigation 1994

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts